This report contains market size and forecasts of Nucleic Acid-based Drugs in Global, including the following market information:
Global Nucleic Acid-based Drugs Market Size 2024-2032, ($ millions)
The global Nucleic Acid-based Drugs market is projected to reach US$ million by 2032.
We surveyed the Nucleic Acid-based Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nucleic Acid-based Drugs Market, by Type, 2024-2032 ($ millions)
Global Nucleic Acid-based Drugs Market Segment Percentages, by Type
ASO
mRNA
siRNA
miRNA
saRNA
Aptamer
Global Nucleic Acid-based Drugs Market, by Application, 2024-2032 ($ millions)
Global Nucleic Acid-based Drugs Market Segment Percentages, by Application
Genetic Disease
Cancer
Cardiovascular Diseases
Other
Global Nucleic Acid-based Drugs Market, By Region and Country, 2024-2032 ($ Millions)
Global Nucleic Acid-based Drugs Market Segment Percentages, by region and country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Ionis Pharmaceuticals
Sarepta Therapeutics
Nippon Shinyaku
BioNTech
Moderna Therapeutics
CureVac
Alnylam Pharmaceuticals
Regulus Therapeutics
Miragen Therapeutics
Mina Therapeutics
NeXstar Pharmaceuticals
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Nucleic Acid-based Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nucleic Acid-based Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nucleic Acid-based Drugs Overall Market Size
2.1 Global Nucleic Acid-based Drugs Market Size: 2023 VS 2032
2.2 Global Nucleic Acid-based Drugs Market Size, Prospects & Forecasts: 2023-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key Nucleic Acid-based Drugs Players in Global Market
3.2 Global Companies Nucleic Acid-based Drugs Product & Technology
4 Nucleic Acid-based Drugs Companies Profiles
4.1 Ionis Pharmaceuticals
4.1.1 Ionis Pharmaceuticals Company Summary
4.1.2 Ionis Pharmaceuticals Business Overview
4.1.3 Ionis Pharmaceuticals Nucleic Acid-based Drugs Product Offerings & Technology
4.1.4 Ionis Pharmaceuticals Nucleic Acid-based Drugs R&D, and Plans
4.2 Sarepta Therapeutics
4.2.1 Sarepta Therapeutics Company Summary
4.2.2 Sarepta Therapeutics Business Overview
4.2.3 Sarepta Therapeutics Nucleic Acid-based Drugs Product Offerings & Technology
4.2.4 Sarepta Therapeutics Nucleic Acid-based Drugs R&D, and Plans
4.3 Nippon Shinyaku
4.3.1 Nippon Shinyaku Company Summary
4.3.2 Nippon Shinyaku Business Overview
4.3.3 Nippon Shinyaku Nucleic Acid-based Drugs Product Offerings & Technology
4.3.4 Nippon Shinyaku Nucleic Acid-based Drugs R&D, and Plans
4.4 BioNTech
4.4.1 BioNTech Company Summary
4.4.2 BioNTech Business Overview
4.4.3 BioNTech Nucleic Acid-based Drugs Product Offerings & Technology
4.4.4 BioNTech Nucleic Acid-based Drugs R&D, and Plans
4.5 Moderna Therapeutics
4.5.1 Moderna Therapeutics Company Summary
4.5.2 Moderna Therapeutics Business Overview
4.5.3 Moderna Therapeutics Nucleic Acid-based Drugs Product Offerings & Technology
4.5.4 Moderna Therapeutics Nucleic Acid-based Drugs R&D, and Plans
4.6 CureVac
4.6.1 CureVac Company Summary
4.6.2 CureVac Business Overview
4.6.3 CureVac Nucleic Acid-based Drugs Product Offerings & Technology
4.6.4 CureVac Nucleic Acid-based Drugs R&D, and Plans
4.7 Alnylam Pharmaceuticals
4.7.1 Alnylam Pharmaceuticals Company Summary
4.7.2 Alnylam Pharmaceuticals Business Overview
4.7.3 Alnylam Pharmaceuticals Nucleic Acid-based Drugs Product Offerings & Technology
4.7.4 Alnylam Pharmaceuticals Nucleic Acid-based Drugs R&D, and Plans
4.8 Regulus Therapeutics
4.8.1 Regulus Therapeutics Company Summary
4.8.2 Regulus Therapeutics Business Overview
4.8.3 Regulus Therapeutics Nucleic Acid-based Drugs Product Offerings & Technology
4.8.4 Regulus Therapeutics Nucleic Acid-based Drugs R&D, and Plans
4.9 Miragen Therapeutics
4.9.1 Miragen Therapeutics Company Summary
4.9.2 Miragen Therapeutics Business Overview
4.9.3 Miragen Therapeutics Nucleic Acid-based Drugs Product Offerings & Technology
4.9.4 Miragen Therapeutics Nucleic Acid-based Drugs R&D, and Plans
4.10 Mina Therapeutics
4.10.1 Mina Therapeutics Company Summary
4.10.2 Mina Therapeutics Business Overview
4.10.3 Mina Therapeutics Nucleic Acid-based Drugs Product Offerings & Technology
4.10.4 Mina Therapeutics Nucleic Acid-based Drugs R&D, and Plans
4.11 NeXstar Pharmaceuticals
4.11.1 NeXstar Pharmaceuticals Company Summary
4.11.2 NeXstar Pharmaceuticals Business Overview
4.11.3 NeXstar Pharmaceuticals Nucleic Acid-based Drugs Product Offerings & Technology
4.11.4 NeXstar Pharmaceuticals Nucleic Acid-based Drugs R&D, and Plans
5 Sights by Region
5.1 By Region - Global Nucleic Acid-based Drugs Market Size, 2024 & 2032
5.2 By Region - Global Nucleic Acid-based Drugs Revenue, (2024-2032)
5.3 United States
5.3.1 Key Players of Nucleic Acid-based Drugs in United States
5.3.2 United States Nucleic Acid-based Drugs Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of Nucleic Acid-based Drugs in Europe
5.4.2 Europe Nucleic Acid-based Drugs Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of Nucleic Acid-based Drugs in China
5.5.2 China Nucleic Acid-based Drugs Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global Nucleic Acid-based Drugs Market Size Markets, 2024 & 2032
6.2 ASO
6.3 mRNA
6.4 siRNA
6.5 miRNA
6.6 saRNA
6.7 Aptamer
7 Sights by Application
7.1 By Application - Global Nucleic Acid-based Drugs Market Size, 2024 & 2032
7.2 Genetic Disease
7.3 Cancer
7.4 Cardiovascular Diseases
7.5 Other
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Nucleic Acid-based Drugs Market Opportunities & Trends in Global Market
Table 2. Nucleic Acid-based Drugs Market Drivers in Global Market
Table 3. Nucleic Acid-based Drugs Market Restraints in Global Market
Table 4. Key Players of Nucleic Acid-based Drugs in Global Market
Table 5. Global Companies Nucleic Acid-based Drugs Product & Technology
Table 6. Ionis Pharmaceuticals Company Summary
Table 7. Ionis Pharmaceuticals Nucleic Acid-based Drugs Product Offerings
Table 8. Sarepta Therapeutics Company Summary
Table 9. Sarepta Therapeutics Nucleic Acid-based Drugs Product Offerings
Table 10. Nippon Shinyaku Company Summary
Table 11. Nippon Shinyaku Nucleic Acid-based Drugs Product Offerings
Table 12. BioNTech Company Summary
Table 13. BioNTech Nucleic Acid-based Drugs Product Offerings
Table 14. Moderna Therapeutics Company Summary
Table 15. Moderna Therapeutics Nucleic Acid-based Drugs Product Offerings
Table 16. CureVac Company Summary
Table 17. CureVac Nucleic Acid-based Drugs Product Offerings
Table 18. Alnylam Pharmaceuticals Company Summary
Table 19. Alnylam Pharmaceuticals Nucleic Acid-based Drugs Product Offerings
Table 20. Regulus Therapeutics Company Summary
Table 21. Regulus Therapeutics Nucleic Acid-based Drugs Product Offerings
Table 22. Miragen Therapeutics Company Summary
Table 23. Miragen Therapeutics Nucleic Acid-based Drugs Product Offerings
Table 24. Mina Therapeutics Company Summary
Table 25. Mina Therapeutics Nucleic Acid-based Drugs Product Offerings
Table 26. NeXstar Pharmaceuticals Company Summary
Table 27. NeXstar Pharmaceuticals Nucleic Acid-based Drugs Product Offerings
Table 28. By Region? Global Nucleic Acid-based Drugs Revenue, (US$, Mn), 2024 & 2032
Table 29. By Region - Global Nucleic Acid-based Drugs Revenue, (US$, Mn), 2024-2032
Table 30. By Type ? Global Nucleic Acid-based Drugs Market Size, (US$, Mn), 2024 & 2032
Table 31. By Application? Global Nucleic Acid-based Drugs Market Size, (US$, Mn), 2024 & 2032
List of Figures
Figure 1. Nucleic Acid-based Drugs Segment by Type in 2032
Figure 2. Nucleic Acid-based Drugs Segment by Application in 2032
Figure 3. Global Nucleic Acid-based Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Nucleic Acid-based Drugs Market Size: 2023 VS 2032 (US$, Mn)
Figure 6. Global Nucleic Acid-based Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global Nucleic Acid-based Drugs Revenue Market Share, 2024-2032
Figure 8. By Type - Global Nucleic Acid-based Drugs Revenue Market Share, 2024-2032
Figure 9. By Application - Global Nucleic Acid-based Drugs Revenue Market Share, 2024-2032
